About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
Palmer2014 - Effect of IL-1β-Blocking therapies in T2DM - Disease Condition This is the model with disease state initial conditions. A few changes were made to the model equations in order to bypass t.
Manifest
{
"io": {
"inputs": [
{
"name": "kglucose",
"label": "Kglucose",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.kglucose",
"description": "Source parameter exposed because its SBML label indicates a boundary, stimulus, dose, ligand, protocol, substrate, or environmental control. Maps to SBML symbol `Kglucose`."
}
],
"outputs": [
{
"name": "state",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.state"
},
{
"name": "summary",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.summary"
},
{
"name": "species_labels",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.species_labels"
},
{
"name": "insulin",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.insulin"
},
{
"name": "proinsulin",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.proinsulin"
},
{
"name": "glucose",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.glucose"
},
{
"name": "il1_ra",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.il1_ra"
},
{
"name": "hba1c",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.hba1c"
},
{
"name": "rbc1",
"maps_to": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.rbc1"
}
]
},
"tags": [
"systemsbiology",
"sbml",
"biomodels_ebi",
"faithful",
"curated"
],
"title": "Palmer2014 Effect Of Il 1 Blocking Therapies In T2dm Disease Conditio Lab",
"models": [
{
"path": "models/core",
"alias": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model_state"
],
"from": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.state"
},
{
"to": [
"visualisation.systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model_summary"
],
"from": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.summary"
},
{
"to": [
"visualisation.systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model_species_labels"
],
"from": "systemsbiology_sbml_palmer2014_effect_of_il_1_blocking_therapies_in_biomd0000000620_model.species_labels"
}
],
"package": "palmer2014-effect-of-il-1-blocking-therapies-in-t2dm-di-47043d60",
"runtime": {
"duration": 1,
"initial_inputs": {},
"communication_step": 0.1
},
"version": "1.0.0",
"description": "Palmer2014 - Effect of IL-1β-Blocking therapies in T2DM - Disease Condition This is the model with disease state initial conditions. A few changes were made to the model equations in order to bypass t.",
"schema_version": "2.0"
}Runtime
Duration1
Comms Step0.1
Runs
Total0
Completed0
Failed0
Metadata
Packagepalmer2014-effect-of-il-1-blocking-therapies-in-t2dm-di-47043d60
Created2026-05-17
Updated2026-06-13
systemsbiologysbmlbiomodels_ebifaithfulcuratedvisualisationother